http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104844705-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 |
| filingDate | 2015-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104844705-B |
| titleOfInvention | Application of the KCTD12 albumen in cell cycle regulating |
| abstract | The invention belongs to protein science technical fields, specifically disclose application of the KCTD12 albumen in cell cycle regulating.It the KCTD12 protein regulation cell cycles, is realized by following approach：In the S phases by controlling the palliating degradation degree of KCTD12 albumen come cell cycle regulation；Or, in the M phases by the phosphorylation and dephosphorylation of control KCTD12 albumen come cell cycle regulation；Or, in the M phases by adjusting interaction of the KCTD12 albumen with CDK1 albumen come cell cycle regulation.KCTD12 albumen of the present invention can be used as the new target drone of cancer cell multiplication regulation and control；Be conducive to develop more anticancer drugs. |
| priorityDate | 2015-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 69.